Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00265928
Status:
TERMINATED
Last Update Posted:
2008-01-28
First Post:
2005-12-14
Brief Title:
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma
Sponsor:
Organization:
National Cancer Institute NCI